EPCAM and neoplasm: In vivo, pimozide reduces the tumor burden in the nude mice xenograft model (43) and affects cell viability on Hep3B and HepG2 cells by inhibition of·Wnt/β-catenin signaling and EpCAM gene and protein expression (44).